{
    "medical_history": {
        "chief_complaint": "Therapy-related acute myeloid leukemia (t-AML) after treatment for early-onset breast and ovarian cancers.",
        "history_of_present_illness": "The patient, a 37-year-old woman, initially presented with stage II breast cancer treated with surgery, radio-, and chemotherapy. At age 39, she developed stage IIIC ovarian cancer, treated similarly. The ovarian cancer recurred at age 42, leading to more chemotherapy. Six months later, she presented with t-AML, characterized by 76% blast cells in bone marrow and complex karyotype changes, and she died 8 days post-presentation.",
        "past_medical_history": "Early-onset breast cancer at age 37, stage II ovarian cancer at age 39, ovarian cancer recurrence at age 42, and t-AML diagnosed at age 42.",
        "family_history": "No first-degree relatives, including parents and children, had cancer.",
        "social_history": "Not specified."
    }
}